Cancer

News

Merck & Co's Keytruda approved for second "tumour agnostic" ...

Merck & Co’s Keytruda cancer immunotherapy has been approved by the FDA in another “tumour agnostic” use, in patients with high levels of mutation.

News

NICE backs funding for Roche's lung cancer drug after price ...

NICE has recommended NHS funding for Roche’s Rozlytrek (entrectinib) as a treatment option for advanced non-small cell lung cancer with a rare mutation in final draft guidance.

Views & Analysis

Bringing men out of isolation after a cancer diagnosis

Studies show that men often isolate themselves when diagnosed with cancer – which can have severe impacts on mental health and outcomes.

Views & Analysis

ASCO 2020 round-up: Virtual conference still delivers the dr...

ASCO may have been virtual this year because of the COVID-19 pandemic, but there were still some show-stopping moments, reports Richard Staines. This time of year oncologists from

News